Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Avivagen Inc. (VIVXF : OTC)
 
 • Company Description   
Avivagen Inc. is a life-sciences company. It is engaged in developing and commercializing products to replace antibiotics in livestock feeds to optimize the health and growth of the animals by supporting the animal's own health defences. Avivagen Inc. is based in Ottawa, Canada.

Number of Employees: 13

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.16 Daily Weekly Monthly
20 Day Moving Average: 4,522 shares
Shares Outstanding: 65.77 (millions)
Market Capitalization: $10.33 (millions)
Beta: 0.21
52 Week High: $0.38
52 Week Low: $0.15
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.13% 12.76%
12 Week -11.70% -2.93%
Year To Date -32.62% -17.67%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
100 Sussex Drive
-
Ottawa,A6 K1A 0R6
CAN
ph: 613-702-2908
fax: -
d.basek@avivagen.com http://www.avivagen.com
 
 • General Corporate Information   
Officers
Kym Anthony - Chief Executive Officer and Chairman
David Hankinson - Vice Chairman of the Board
Chris Boland - Chief Financial Officer
Aubrey Dan - Director
Paul Mesburis - Director

Peer Information
Avivagen Inc. (BJCT)
Avivagen Inc. (CADMQ)
Avivagen Inc. (APNO)
Avivagen Inc. (UPDC)
Avivagen Inc. (IMTIQ)
Avivagen Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 05382F202
SIC: 8880
Fiscal Year
Fiscal Year End: October
Last Reported Quarter: 01/01/22
Next Expected EPS Date: 06/01/22
Share - Related Items
Shares Outstanding: 65.77
Most Recent Split Date: (:1)
Beta: 0.21
Market Capitalization: $10.33 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.02 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.07 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 06/01/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 9.64
EPS Growth
vs. Year Ago Period: -50.00%
vs. Previous Quarter: -50.00%
Sales Growth
vs. Year Ago Period: 17.16%
vs. Previous Quarter: -18.43%
ROE
04/30/22 - -
01/31/22 - -
10/31/21 - -
ROA
04/30/22 - -
01/31/22 - -143.06
10/31/21 - -161.72
Current Ratio
04/30/22 - -
01/31/22 - -
10/31/21 - 0.53
Quick Ratio
04/30/22 - -
01/31/22 - -
10/31/21 - 0.33
Operating Margin
04/30/22 - -
01/31/22 - -511.11
10/31/21 - -491.22
Net Margin
04/30/22 - -
01/31/22 - -511.11
10/31/21 - -491.22
Pre-Tax Margin
04/30/22 - -
01/31/22 - -
10/31/21 - -493.21
Book Value
04/30/22 - -
01/31/22 - -
10/31/21 - -0.06
Inventory Turnover
04/30/22 - -
01/31/22 - -
10/31/21 - 0.82
Debt-to-Equity
04/30/22 - -
01/31/22 - -
10/31/21 - -
Debt-to-Capital
04/30/22 - -
01/31/22 - -
10/31/21 - -
 

Powered by Zacks Investment Research ©